Loading clinical trials...
Loading clinical trials...
A Phase III, 12-week, Multicentre, Multinational, Randomised, Double-blind, Double-dummy, 3 Arm-parallel Group Study to Test the Efficacy of CHF 1535 (Fixed Combination of Beclomethasone Dipropionate (BDP) Plus Formoterol Fumarate (FF)) Versus a Free Combination of Beclomethasone Dipropionate Plus Formoterol Fumarate and Versus a Monotherapy of Beclomethasone Dipropionate in Partly Controlled Asthmatic Children
Conditions
Interventions
CHF 1535
Beclomethasone (BDP)
+1 more
Locations
11
Bulgaria
UMHAT "Alexandrovska
Plovdiv, Bulgaria
Necker Enfants Malades Hospital
Paris, France
Drez. Gelb & Knecht
Bretten, Germany
Micro Care Kft
Szigetvár, Hungary
G.Gaslini Institute
Genoa, Italy
Uniwersytetu Medycznego
Lodz, Poland
Start Date
September 1, 2011
Primary Completion Date
September 1, 2012
Completion Date
September 1, 2012
Last Updated
March 29, 2017
NCT07486401
NCT07219173
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
Chiesi Farmaceutici S.p.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions